from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3478/PPE60

LFCtreatmentdescriptionclass of inhibitor

0.305

Amikacinug/mL Amikacintranslation

0.368

Cap5-10ug/mL Capreomycintranslation

0.521

Rox10-50 ug/mL Roxithromycintranslation

-0.146

SM2-5 ug/mL Streptomycintranslation

0.308

Tet5-10 ug/mL Tetracyclinetranslation

-1.111

Rif0.2-5ug/mL Rifampicintranscription

-0.841

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.976

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.588

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.155

CPZ10-50 ug/mL Chlorpromazinerespiration

0.335

Clofazimine10-13 ug/mL Clofaziminerespiration

0.487

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.996

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.327

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.887

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.362

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.023

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.170

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.002

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.102

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.551

KCN5-20 ug/mL Potassium cyaniderespiration

-0.332

NaN30.2-2 mM Sodium aziderespiration

0.443

Nigericin50 uM Nigericinrespiration

-1.456

TRC10-150 ug/mL Triclosanrespiration

-0.663

TRZ10-25 ug/mL Thioridazinerespiration

-1.671

Valinomycin0.5-10 uM Valinomycinrespiration

1.326

ZnSO42 mM ZnSO4respiration

-1.655

menadione6-10 ug/mL Menadionerespiration

0.790

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.609

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.775

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.724

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.805

NRP_1Non-replicating persistence stage 1dosRassociated

0.869

Amp0.2mg/mL AmpicillincellWall

0.701

Cephalexin20-100 ug/mL CephalexincellWall

0.069

Cerulenin0.32-5 ug/mL CerulenincellWall

0.572

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.603

EMB10-20 ug/mL EthambutolcellWall

0.680

Eta12-40 ug/mL EthionamidecellWall

0.941

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.127

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.164

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.026

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.444

BZA0.12 mg/mL BenzamidearomaticAmides

-0.239

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.590

H2O24 mM hydrogen peroxideDNAdamaging

0.379

Levo10 ug/mL LevofloxacinDNAdamaging

0.336

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.152

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.410

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.624

UVUV-irradiationDNAdamaging

-1.255

ARP41-4 ug/mL Antitubercular compound ARP4?

0.691

Antimycin12.5-50 ug/mL Antimycin A?

0.559

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.498

PA_110-50 ug/mL Antitubercular compound PA-1?

0.632

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.783

PA8240.2-2 ug/mL PA-824?

-0.720

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.196

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.530

Verapamil50 uM Verapamil?

0.720

mercaptoethanol2 mM 2-Mercaptoethanol?

0.175

methoxatin10-20 ug/mL Methoxatin?